LondonNICE will now fund Enhertu for 1,000 women.

The reversal followed a US-UK trade deal, not a new clinical trial.

NICE funds drugs only below a cost-per-QALY threshold that has sat flat for two decades.

Whether the raised threshold will unlock other refused drugs remains unclear.

How each outlet framed it
STAT
links NHS coverage to US-UK pricing deal that raised cost-effectiveness thresholds for drug approval

Sources: STAT